elder law weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of elder law weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
International Obesity Task Force
Data demonstrate cardiovascular impact of weight loss with sibutramine
June 23rd, 2004
Data presented at the 13th European Congress on Obesity explored the reduction of cardiovascular risk factors associated with being obese among patients who lost weight with sibutramine treatment. The data presented at the congress demonstrated the relationship of weight loss with sibutramine to improvements in obesity-associated cardiovascular risk factors including metabolic syndrome, reduced left ventricular mass, and lowered predicted risk of coronary heart disease (CHD). "Cardiovascular-related conditions including hypertension, dyslipidemia and type 2 diabetes are all serious risks for obese patients," stated professor Arya M. Sharma MD, PhD,...
Source: elder law weekly (2004-06-23)
|
